Free Trial

Xenetic Biosciences (XBIO) Earnings Date, Estimates & Call Transcripts

Xenetic Biosciences logo
$3.66 +0.01 (+0.27%)
(As of 11/14/2024 ET)

Xenetic Biosciences Latest Earnings Summary

Upcoming
Earnings Date
Mar. 20Estimated
Actual EPS
(Nov. 12)
-$0.28 Missed By -$0.14
Consensus EPS
(Nov. 12)
-$0.14

Xenetic Biosciences announced Q3 2024 earnings on November 12, 2024, reporting an EPS of -$0.28, which missed the consensus estimate of -$0.14 by $0.14. Quarterly revenue was reported to be $0.61 million, below analysts' expectations of $0.75 million. With a trailing EPS of -$2.66, Xenetic Biosciences' earnings are expected to grow next year, from ($1.01) to ($0.66) per share.

XBIO Upcoming Earnings

Xenetic Biosciences' next earnings date is estimated for Thursday, March 20, 2025, based off prior year's reporting schedules.

Get Xenetic Biosciences Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Xenetic Biosciences and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

XBIO Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

XBIO Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Xenetic Biosciences Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20241-$0.79-$0.79-$0.79
Q2 20241-$0.83-$0.83-$0.83
Q3 20241-$0.14-$0.14-$0.14
Q4 20241-$0.20-$0.20-$0.20
FY 20244($1.96)($1.96)($1.96)

Xenetic Biosciences Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks
3/20/2025
(Estimated)
------- 
11/12/2024--$0.14-$0.28 -$0.14-$0.28$0.75M$0.61M
8/13/2024--$0.83-$0.83--$0.83$0.54M$0.73M
5/9/2024Q1 2024-$0.79-$0.78+$0.01-$0.78$0.65M$0.51M
3/21/2024Q4 2023-$0.87-$0.77+$0.10-$0.77$0.68M$0.67M
11/10/2023Q3 2023-$1.12-$0.69+$0.43-$0.69$0.46M$0.61M
8/11/2023Q2 2023-$1.13-$0.69+$0.44-$0.69$0.44M$0.65M
5/11/2023Q1 2023-$1.10-$0.60+$0.50-$0.60$0.41M$0.61M
3/23/2023Q4 2022--$1.00 -$1.00-$1.00$0.18M$0.49M

Xenetic Biosciences Earnings - Frequently Asked Questions

Xenetic Biosciences has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 20th, 2025 based off last year's report dates. Learn more on XBIO's earnings history.

In the previous quarter, Xenetic Biosciences (NASDAQ:XBIO) missed the analysts' consensus estimate of ($0.14) by $0.14 with a reported earnings per share (EPS) of ($0.28). Learn more on analysts' earnings estimate vs. XBIO's actual earnings.

Xenetic Biosciences (NASDAQ:XBIO) has a recorded annual revenue of $2.52 million.

Xenetic Biosciences (NASDAQ:XBIO) has a recorded net income of -$4.14 million. XBIO has generated -$2.66 earnings per share over the last four quarters.

Xenetic Biosciences's earnings are expected to grow from ($1.01) per share to ($0.66) per share in the next year.

`

More Earnings Resources from MarketBeat



This page (NASDAQ:XBIO) was last updated on 11/14/2024 by MarketBeat.com Staff
From Our Partners